Journal article · 2025 · Open access

Redefining Targeted Therapy Through Protein Degradation Using Proteolysis Targeting Chimeras

Vanitha Devi Rajendran, Guruprasath Kumar, Saifdeen Shabeer Ahamed, Abinaya Selvarasu, Balakumar Palanivelu, Vinoth Jeevanesan

International Journal of Pharmacy and Industrial Research · Published 26 July 2025

Open PDFView at the publisherCite this paper

In brief

“Redefining Targeted Therapy Through Protein Degradation Using Proteolysis Targeting Chimeras” is a 2025 journal article by Vanitha Devi Rajendran and 5 co-authors, published in International Journal of Pharmacy and Industrial Research. OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at International Journal of Pharmacy and Industrial Research.

Citations
0
References
36
Authors
6

Abstract

Proteolysis Targeting Chimeras (PROTACs) represent a novel class of heterobifunctional molecules designed to induce selective degradation of disease-associated proteins via the ubiquitin–proteasome system. Each PROTAC molecule consists of two ligands, one that binds the protein of interest and another that recruits an E3 ubiquitin ligase, connected by a flexible linker. Upon forming a ternary complex, PROTACs facilitate polyubiquitination of the target protein, marking it for degradation by the 26S proteasome. Unlike traditional inhibitors, PROTACs eliminate proteins rather than inhibit their activity, allowing them to target shallow or transient binding sites and previously “undruggable” proteins. Their catalytic mechanism enables sustained protein knockdown at substoichiometric concentrations. PROTACs are showing promising therapeutic utility, particularly in oncology, where aberrant or misfolded proteins disrupt cellular homeostasis. This review outlines the mechanistic basis of PROTAC function, highlights emerging clinical applications and discusses current challenges and future directions in advancing this transformative therapeutic strategy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rajendran, V. D., Kumar, G., Ahamed, S. S., Selvarasu, A., Palanivelu, B., & Jeevanesan, V. (2025). Redefining Targeted Therapy Through Protein Degradation Using Proteolysis Targeting Chimeras. International Journal of Pharmacy and Industrial Research. https://www.ijpir.com/index.php/ijpir/article/view/595

MLA 9

Rajendran, Vanitha Devi, et al. “Redefining Targeted Therapy Through Protein Degradation Using Proteolysis Targeting Chimeras.” International Journal of Pharmacy and Industrial Research, 2025. https://www.ijpir.com/index.php/ijpir/article/view/595.

Chicago

Rajendran, Vanitha Devi, Guruprasath Kumar, Saifdeen Shabeer Ahamed, Abinaya Selvarasu, Balakumar Palanivelu, and Vinoth Jeevanesan. 2025. “Redefining Targeted Therapy Through Protein Degradation Using Proteolysis Targeting Chimeras.” International Journal of Pharmacy and Industrial Research. https://www.ijpir.com/index.php/ijpir/article/view/595.

Harvard

Rajendran, V. D. et al. (2025) ‘Redefining Targeted Therapy Through Protein Degradation Using Proteolysis Targeting Chimeras’, International Journal of Pharmacy and Industrial Research. Available at: https://www.ijpir.com/index.php/ijpir/article/view/595.

IEEE

V. D. Rajendran, G. Kumar, S. S. Ahamed, A. Selvarasu, B. Palanivelu, and V. Jeevanesan, “Redefining Targeted Therapy Through Protein Degradation Using Proteolysis Targeting Chimeras,” International Journal of Pharmacy and Industrial Research, 2025.

BibTeX

@article{rajendran2025redefining,
  title     = {{Redefining Targeted Therapy Through Protein Degradation Using Proteolysis Targeting Chimeras}},
  author    = {Rajendran, Vanitha Devi and Kumar, Guruprasath and Ahamed, Saifdeen Shabeer and Selvarasu, Abinaya and Palanivelu, Balakumar and Jeevanesan, Vinoth},
  journal   = {International Journal of Pharmacy and Industrial Research},
  year      = {2025},
  url       = {https://www.ijpir.com/index.php/ijpir/article/view/595}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • targeted protein degradation
  • ubiquitin-proteasome system
  • E3 ubiquitin ligase
  • polyubiquitination
  • 26S proteasome
  • heterobifunctional molecules
  • undruggable proteins

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Rajendran, V. D., Kumar, G., Ahamed, S. S., Selvarasu, A., Palanivelu, B., & Jeevanesan, V. (2025). Redefining Targeted Therapy Through Protein Degradation Using Proteolysis Targeting Chimeras. International Journal of Pharmacy and Industrial Research. https://www.ijpir.com/index.php/ijpir/article/view/595

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Pharmacy and Industrial Research: sign in and open the PDF from this page.

Who wrote this paper?

Vanitha Devi Rajendran, Guruprasath Kumar, Saifdeen Shabeer Ahamed, Abinaya Selvarasu, Balakumar Palanivelu, Vinoth Jeevanesan.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.